BB
BMY.RT

Busey Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Busey Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77,781
Closed -$54K – 322
2020
Q4 		$54K Sell
77,781
-4,076
-5% -$8.68K ﹤0.01% 311
2020
Q3 		$185K Sell
81,857
-2,177
-3% -$6.22K 0.01% 312
2020
Q2 		$282K Sell
84,034
-1,722
-2% -$6.21K 0.02% 260
2020
Q1 		$288K Buy
85,756
+25,613
+43% +$84.4K 0.02% 248
2019
Q4 		$135K Buy
+60,143
New +$156K 0.01% 334

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Busey Bank's BMY.RT Position: Q1 2021 in Review

Busey Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 77,781 shares — an estimated $54K sold.

Busey Bank first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $288K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Busey Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Busey Bank sold 77,781 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $54K.
  • Busey Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Busey Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $288K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Busey Bank's 13F filing for Q1 2021, filed 20 Apr 2021.